SEI Investments’s Fortress Biotech FBIO Stock Holding History

SEI Investments’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-42	Closed	-$2K	–	2763
2018 Q2	$2K	Buy	+42	New	+$2.37K	﹤0.01%	3337

Other funds holding FBIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GPCM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

STRS Ohio Columbus, Ohio $25.2B AUM 30.31% 1-Year Est. Return

OPPM

Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return

SEI Investments's FBIO Position: Q3 2018 in Review

SEI Investments sold out of Fortress Biotech (FBIO) in Q3 2018, closing a stake of 42 shares — an estimated $2K sold.

SEI Investments first reported a position in FBIO in Q2 2018 and held it in 1 quarter. The position peaked at $2K in Q2 2018. 65 funds tracked by Wall St. Rank hold FBIO as of Q3 2018.

SEI Investments reported no remaining Fortress Biotech position as of Q3 2018 after selling out during the quarter.
SEI Investments sold 42 Fortress Biotech shares in Q3 2018, an estimated $2K.
SEI Investments first reported a position in Fortress Biotech in Q2 2018 and held it in 1 quarter.
SEI Investments's Fortress Biotech position peaked at $2K in Q2 2018.
65 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2018.

Based on SEI Investments's 13F filing for Q3 2018, filed 8 Nov 2018.